Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000067024A1 Cancer treatment with endothelin receptor antagonists
11/09/2000WO2000067023A1 Screening for immunostimulatory dna functional modifyers
11/09/2000WO2000067016A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066787A2 Growth hormone-regulatable liver genes and proteins, and uses thereof
11/09/2000WO2000066782A2 Diagnostic assay for diabetes mellitus based on mutational burden
11/09/2000WO2000066778A1 Pituitrone gene and polypeptides
11/09/2000WO2000066773A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents
11/09/2000WO2000066766A1 Optical probes and assays
11/09/2000WO2000066761A2 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase
11/09/2000WO2000066755A2 Pesticidal fusions
11/09/2000WO2000066753A2 Modified vitamin k-dependent polypeptides
11/09/2000WO2000066752A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide
11/09/2000WO2000066743A2 Viral expression vectors
11/09/2000WO2000066742A2 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants
11/09/2000WO2000066741A2 Conserved neisserial antigens
11/09/2000WO2000066740A1 Flagellin peptides and receptors
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066738A1 Process for producing recombinant insulin from novel fused protein
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066734A1 Methods of treating hypertension
11/09/2000WO2000066733A1 Protein specific for cardiac and skeletal muscle
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066729A1 Meg-3 protein
11/09/2000WO2000066728A1 StAR HOMOLOGUES
11/09/2000WO2000066727A1 Tumour-associated antigen
11/09/2000WO2000066726A1 Novel cellular regulation factor tto 20
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066717A1 Human brain carboxypeptidase b
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066707A2 Novel thiamine transporter, a polynucleotide encoding same and their uses
11/09/2000WO2000066632A1 Agonists or antagonists for haemopoietic growth factors
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066629A1 Modified exendins and exendin agonists
11/09/2000WO2000066628A1 Neurite outgrowth and guidance by tenascin-c
11/09/2000WO2000066627A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000WO2000066626A1 Novel peptide y-2
11/09/2000WO2000066624A1 Helicobacter pylori antigens
11/09/2000WO2000066623A2 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
11/09/2000WO2000066622A1 T20/dp178 and t21/dp107 are activators of human phagocyte formyl peptide receptors
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066619A2 Means and methods for altering the functional properties in eukaryotic cells
11/09/2000WO2000066617A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000WO2000066616A1 METHODS AND COMPOSITIONS FOR CONTROLLING DENTAL CARIES, AND RECOMBINANT SmaA POLYPEPTIDES USEFUL FOR SAME
11/09/2000WO2000066615A1 Compositions and methods for detection of active proteases
11/09/2000WO2000066610A1 Apple promoters for expression of transgenes in plants
11/09/2000WO2000066608A1 Tumor necrosis factor-gamma
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066177A1 GENE THERAPY USING TGF-$g(b)
11/09/2000WO2000066162A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066153A1 RAS ONCOGEN p21 PEPTIDE VACCINES
11/09/2000WO2000066151A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066146A1 Structure-based design of compounds that inhibit detrimental cytotoxic t lymphocyte responses
11/09/2000WO2000066143A1 Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066090A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000065908A1 Traf5 knockout mouse
11/09/2000WO2000053759A8 Expression of human alpha-fetoprotein in mammalian cells
11/09/2000WO2000042195B1 Schizochytrium pks genes
11/09/2000WO2000040604A3 METHODS AND COMPOSITIONS FOR MODULATING CYTOKINE RELEASE BY αEβ7-EXPRESSING CELLS
11/09/2000WO2000039323A3 Production of proteins in gram-positive microorganisms
11/09/2000WO2000039293A3 Agent for inhibiting the regeneration of tissue
11/09/2000WO2000039277A3 Ndsp nucleic acids and polypeptides
11/09/2000WO2000037645A3 Cell cycle nucleic acids, polypeptides and uses thereof
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000037489A3 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same
11/09/2000WO2000037105A3 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000036115A3 Plant carbon catabolite repression proteins
11/09/2000WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/09/2000WO2000035421A3 Integrative protein-dna cochleate formulations and methods for transforming cells
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000034461A3 Compositions and methods of modulating cholesterol metabolism
11/09/2000WO2000034438A3 Method for constructing libraries of phenotypic profiles
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032630A3 Nucleic acids and polypeptides derived from activated eosinophil cells and use thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000029621A3 Method for measuring target polynucleotides and novel asthma biomolecules
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000029439A9 The cxc chemokine h174 and methods for preventing damage to the nervous system
11/09/2000WO2000029429A3 Endoplasmic reticulum stress transcription factors atf6 and creb-rp
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000WO2000029000A9 Compositions and methods for recombinational cloning of nucleic acid molecules
11/09/2000WO2000028036A3 Disease resistance factors
11/09/2000WO2000028034A3 Cytokine signal regulators
11/09/2000WO2000028033A3 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
1 ... 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 ... 2916